Fungal folliculitis masquerading as acute exanthematous pustulosis
A 25-year-old man being treated in the hospital for catatonia and fl accid paralysis developed fever and a lobar consolidation, prompting treatment with piperacillin-tazobactam. A dermatology consult was called 3 days later when the patient developed a rash on the forehead (Figure 1) , cheeks, chin, and upper trunk, raising concern for a drug-related eruption.
Close examination of the rash revealed bright red plaques studded with sheets of monomorphic pustules. Possible causes other than drug therapy were considered, including folliculitis, acneiform eruption, and pustular psoriasis. Bacterial culture of a pustule was negative, but punch biopsy of a pustule revealed an abundance of round and oval budding yeast forms consistent with Malassezia (formerly called Pityrosporum) "stuffi ng" the hair follicles and forming cleared spaces in the dermis surrounded by an exuberant lymphohistiocytic infi ltrate (Figures 2 and 3) . Special stains were negative for bacteria and mycelial forms. The clinicopathologic fi ndings were diagnostic of Malassezia folliculitis with formation of dermal abscesses.
The patient was treated with intravenous itraconazole 200 mg daily for 7 days and topical benzoyl peroxide 5% gel, with ketoconazole 2% cream for maintenance therapy. The treatment brought improvement of the rash.
■ THE DIFFERENTIAL DIAGNOSIS
The appearance of sterile pustules after starting a new antibiotic raised suspicion for acute localized exanthematous pustulosis, a variant CLEVELAND CLINIC JOURNAL OF MEDICINE VOLUME 83 • NUMBER 3 MARCH 2016
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of acute generalized exanthematous pustulosis. It is a serious but uncommon adverse drug reaction, with a frequency of one to fi ve cases per million per year. The eruption of erythematous plaques studded with sterile pustules classically appears 1 to 5 days after starting a drug. 1 Piperacillin-tazobactam has been infrequently reported in association with acute exanthematous pustulosis, but antibiotics in general are among the most commonly reported culprits. entiating fungal folliculitis from pustulosis is important, as each condition is treated differently: Malassezia folliculitis is treated with antifungals, 5 and acute localized exanthematous pustulosis is managed with cessation of the offending drug, supportive care, and systemic or topical steroids. Take-home point Our experience with this patient was a reminder to consider fungal folliculitis in the differential diagnosis of a pustular eruption, so as to allow appropriate management and to avert discontinuation of potentially lifesaving medications. 
